Please select the option that best describes you:
Topics:
Psychiatry • Geriatric Psychiatry • General Outpatient Psychiatry • Major Depressive Disorder • Psychopharmacology
What is your approach to patients experiencing withdrawal symptoms or worsening anxiety/agitation when tapering atypical antipsychotics that were originally added to augment unipolar depression treatment?
How do you handle patients who experience worsening anxiety from lowering the atypical antipsychotic dose? What about intense fears surrounding decreasing doses?